Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan

被引:69
作者
Hsueh, PR
Teng, LJ
Yang, PC
Ho, SW
Hsieh, WC
Luh, KT
机构
[1] NATL TAIWAN UNIV HOSP,DEPT LAB MED,TAIPEI 100,TAIWAN
[2] NATL TAIWAN UNIV HOSP,DEPT INTERNAL MED,TAIPEI 100,TAIWAN
[3] NATL TAIWAN UNIV,SCH MED TECHNOL,TAIPEI 10764,TAIWAN
关键词
D O I
10.1007/BF02447918
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
To understand the clinical features, antimicrobial therapy and epidemiology of Chryseobacterium indologenes infections, the medical records of 36 patients with nosocomial Chryseobacterium indologenes infections seen over a three-year period al National Taiwan University Hospital were reviewed. The 36 isolates recovered from these patients were studied by molecular typing and determination of antimicrobial susceptibility patterns. Nine patients had underlying neoplastic diseases, seven had diabetes mellitus, five had burn wounds, and four had uremia. The clinical syndrome included ten patients with intraabdominal infections, nine with wound sepsis, six with intravascular catheter-related bacteremia, and four with ventilator-associated pneumonia. Thirteen patients had monomicrobial bacteremia, and four had polymicrobial bacteremia. Nineteen patients (53%) developed infections associated with various indwelling devices, The deaths of five patients (14%) were directly attributable to infection with Chryseobacterium indologenes, All isolates recovered showed a wide range of resistance to commonly used antimicrobial agents. The random amplified polymorphic DNA (RAPD) patterns of the isolates differed from each other indicating the absence of epidemiological relatedness among these isolates. Nosocomial infection caused by multiresistant Chryseobacterium indologenes appears to be an emerging problem in Taiwan and should be studied further.
引用
收藏
页码:568 / 574
页数:7
相关论文
共 30 条
[11]   ACTIVITY OF MEROPENEM AGAINST ANTIBIOTIC-RESISTANT OR INFREQUENTLY ENCOUNTERED GRAM-NEGATIVE BACILLI [J].
JORGENSEN, JH ;
MAHER, LA ;
HOWELL, AW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) :2410-2414
[12]  
*NAT COMM CLIN LAB, 1993, M7A2 NCCLS
[13]  
NATHAN P, 1983, CRIT REV CLIN LAB SC, V4, P61
[14]  
PEDERSEN MM, 1970, AM J CLIN PATHOL, V54, P178
[15]   METHODS FOR IDENTIFICATION OF FLAVOBACTERIA [J].
PICKETT, MJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (10) :2309-2315
[16]  
POLLACK M, 1995, MANDELL DOUGLAS BENN, P1980
[17]   ANTIBIOTIC-RESISTANCE PATTERN OF FLAVOBACTERIUM-MENINGOSEPTICUM [J].
RAIMONDI, A ;
MOOSDEEN, F ;
WILLIAMS, JD .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (04) :461-463
[18]   FLAVOBACTERIUM-MENINGOSEPTICUM [J].
RATNER, H .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1984, 5 (05) :237-239
[19]   RELAPSE OF CATHETER-RELATED FLAVOBACTERIUM-MENINGOSEPTICUM BACTEREMIA DEMONSTRATED BY DNA MACRORESTRICTION ANALYSIS [J].
SADER, HS ;
JONES, RN ;
PFALLER, MA .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (04) :997-1000
[20]  
SALATA RA, 1987, AM REV RESPIR DIS, V135, P426